187 related articles for article (PubMed ID: 8569595)
1. Measuring of cardiolipin antibodies and plasma lipids in different stages of coronary disease.
Rebić R; Nastić-Mirić D; Pavlović S; Pokrajcić Z; Bosnjaković V
Med Pregl; 1993; 46 Suppl 1():20-2. PubMed ID: 8569595
[TBL] [Abstract][Full Text] [Related]
2. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity].
Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F
Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes.
Biasucci LM; Liuzzo G; Ciervo A; Petrucca A; Piro M; Angiolillo DJ; Crea F; Cassone A; Maseri A
Circulation; 2003 Jun; 107(24):3015-7. PubMed ID: 12796125
[TBL] [Abstract][Full Text] [Related]
4. Anti-cardiolipin antibodies in ischaemic heart disease.
Klemp P; Cooper RC; Strauss FJ; Jordaan ER; Przybojewski JZ; Nel N
Clin Exp Immunol; 1988 Nov; 74(2):254-7. PubMed ID: 3224444
[TBL] [Abstract][Full Text] [Related]
5. [Anticardiolipin antibodies and early infarct of the myocardium].
Gaeta G; Lupoli S; Brancaccio V; Effuso L; Russo V; Boccalatte A
Cardiologia; 1998 Jul; 43(7):731-5. PubMed ID: 9738331
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
7. [Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris].
Nasonov EL; Noeva EA; Kovalev VIu; Dragnev AG; Lopaeva OV; Ruda MIa
Kardiologiia; 1992 May; 32(5):32-4. PubMed ID: 1405256
[TBL] [Abstract][Full Text] [Related]
8. Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities.
Bolibar I; von Eckardstein A; Assmann G; Thompson S;
Thromb Haemost; 2000 Dec; 84(6):955-60. PubMed ID: 11154140
[TBL] [Abstract][Full Text] [Related]
9. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
[TBL] [Abstract][Full Text] [Related]
10. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension.
Türkoğlu O; Bariş N; Kütükçüler N; Senarslan O; Güneri S; Atilla G
J Periodontol; 2008 Feb; 79(2):332-40. PubMed ID: 18251648
[TBL] [Abstract][Full Text] [Related]
12. [Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease].
Márk L; Márki-Zay J; Orosz I; Kondacs A; Erdei F; Katona A
Orv Hetil; 2003 Apr; 144(16):765-8. PubMed ID: 12778627
[TBL] [Abstract][Full Text] [Related]
13. Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction.
Scaglione L; Bergerone S; Gambino R; Imazio M; Macchia G; Cravetto A; Gaschino G; Baralis G; Rosettani E; Pagano G; Cassader M
Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):118-24. PubMed ID: 10464784
[TBL] [Abstract][Full Text] [Related]
14. Effect of phase I periodontal therapy on anti-cardiolipin antibodies in patients with acute myocardial infarction associated with chronic periodontitis.
Gunupati S; Chava VK; Krishna BP
J Periodontol; 2011 Dec; 82(12):1657-64. PubMed ID: 21486181
[TBL] [Abstract][Full Text] [Related]
15. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
[TBL] [Abstract][Full Text] [Related]
16. Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
Wong BY; Gnarpe J; Teo KK; Ohman EM; Prosser C; Gibler WB; Langer A; Chang WC; Armstrong PW
Am Heart J; 2002 Dec; 144(6):987-94. PubMed ID: 12486422
[TBL] [Abstract][Full Text] [Related]
17. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova RA; Hadzhimitova V; Ribarov S
Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
[TBL] [Abstract][Full Text] [Related]
19. [Immunological characteristics of patients with acute coronary syndrome (unstable angina and myocardial infarction)].
Logacheva IV; Leshchinskiĭ LA; Zvorygin IA
Klin Med (Mosk); 1999; 77(4):23-5. PubMed ID: 10356912
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
